Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.


Deligezer U., Yaman F., Darendeliler E., Dizdar Y., Holdenrieder S., Kovancilar M., ...Daha Fazla

Clinica chimica acta; international journal of clinical chemistry, cilt.411, ss.1452-6, 2010 (SCI-Expanded) identifier identifier identifier